Mechanisms and therapeutic potential of chinonin in nervous system diseases

被引:8
|
作者
Hui, Zhang [1 ,4 ]
Wang, Lai-Fa [1 ]
Wang, Xue-Qin [1 ]
Ling, Deng [1 ,2 ]
He, Bin-Sheng [3 ,4 ]
Li, Jian-Ming [1 ,4 ]
机构
[1] Changsha Med Univ, Hunan Prov Univ, Key Lab Fundamental & Clin Res Neurodegenerat Dis, Changsha 410219, Peoples R China
[2] Changsha Med Univ, Hunan Prov Key Lab Res & Dev Novel Pharmaceut Prep, Changsha 410219, Peoples R China
[3] Changsha Med Univ, Hunan Prov Key Lab TCM Agr Biogenom, Changsha 410219, Peoples R China
[4] Changsha Med Univ, Hunan Prov Univ, Key Lab Fundamental & Clin Res Funct Nucl Acid, Changsha 410219, Peoples R China
关键词
Chinonin; nervous system diseases; neurological function; neuroprotection; molecular mechanism; NF-KAPPA-B; NLRP3; INFLAMMASOME; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ASSISTED EXTRACTION; BRAIN-INJURY; MOUSE MODEL; MANGIFERIN; ACTIVATION; NEUROINFLAMMATION;
D O I
10.1080/10286020.2024.2371040
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The flavonoid compound chinonin is one of the main active components of Rhizoma anemarrhena with multiple activities, including anti-inflammatory and antioxidant properties, protection of mitochondrial function and regulation of immunity. In this paper, we reviewed recent research progress on the protective effect of chinonin on brain injury in neurological diseases. "Chinonin" OR "Mangiferin" AND "Nervous system diseases" OR "Neuroprotection" was used as the terms for search in PumMed. After discarding duplicated and irrelevant articles, a total of 23 articles relevant to chinonin published between 2012 and 2023 were identified in our study. [GRAPHICS] .
引用
收藏
页码:1405 / 1420
页数:16
相关论文
共 50 条
  • [1] The therapeutic potential of stem cells for nervous system diseases
    Isacson, O
    ARCHIVES OF NEUROLOGY, 2003, 60 (02) : 295 - 295
  • [2] Therapeutic potential of small interfering RNA for central nervous system diseases
    Lovett-Racke, AE
    Cravens, PD
    Gocke, AR
    Racke, MK
    Stüve, O
    ARCHIVES OF NEUROLOGY, 2005, 62 (12) : 1810 - 1813
  • [3] Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
    Huang, Yinrou
    Zhao, Mengke
    Chen, Xuemei
    Zhang, Ruoyu
    Le, Anh
    Hong, Michael
    Zhang, Yufei
    Jia, Lin
    Zang, Weidong
    Jiang, Chao
    Wang, Junmin
    Fan, Xiaochong
    Wang, Jian
    AGING AND DISEASE, 2023, 14 (03): : 858 - 878
  • [4] The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
    Tan, Rui
    Hong, Rui
    Sui, Chunxiao
    Yang, Dianxu
    Tian, Hengli
    Zhu, Tao
    Yang, Yang
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [5] The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases
    Zuo, Shilun
    Li, Qiang
    Liu, Xin
    Feng, Hua
    Chen, Yujie
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [6] Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases
    Zhou, Ji-Yin
    Zhou, Shi-Wen
    FITOTERAPIA, 2012, 83 (04) : 617 - 626
  • [7] Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases
    Zhang, Yue
    Sun, Meiyan
    Zhao, Hongxiang
    Wang, Zhengyan
    Shi, Yanan
    Dong, Jianxin
    Wang, Kaifang
    Wang, Xi
    Li, Xingyue
    Qi, Haiyan
    Zhao, Xiaoyong
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 7559 - 7581
  • [8] Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases
    Tu, Jie
    Wang, Li-Ping
    NEUROSCIENCE BULLETIN, 2009, 25 (01) : 27 - 32
  • [9] HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
    Mao, Di
    Zheng, Yuan
    Xu, Fenfen
    Han, Xiao
    Zhao, Hongyang
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence
    Banister, Samuel D.
    Kassiou, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (07) : 884 - 901